title: Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement.
authors.forename: C
authors.initials: C
authors.lastname: Deighton
authors.forename: K
authors.initials: K
authors.lastname: Hyrich
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005602:France; D019983:Guideline Adherence; D054625:Healthcare Disparities; D006801:Humans; D018579:Patient Selection; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D006113:United Kingdom
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha